• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza

Giuseppe

Emeritus
Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza (Abstract, edited)


[Source: Imperial College London, full PDF Document (LINK). Abstract, edited.]

Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza

Yan Liu 1*, Robert A. Childs 1*, Tatyana Matrosovich 2*, Stephen Wharton 3,4 , Angelina S. Palma 4, Wengang Chai 1, Rodney Daniels 3, Victoria Gregory 3, Jennifer Uhlendorff 2,5 , Makoto Kiso 5, Hans-Dieter Klenk 2, Alan Hay 3, Ten Feizi 1** and Mikhail Matrosovich 2** 6

1 The Glycosciences Laboratory, Department of Medicine, Imperial College London, Northwick Park and St. Mark?s Campus, Harrow, Middlesex HA1 3UJ, UK; 2 Institute of Virology, Philipps University, Hans-Meerwein-Str.2, 35043, Marburg, Germany; 3 Division of Virology, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK; 4 REQUIMTE, Centro de Qu?mica Fina e Biotecnologia, Departamento de Qu?mica, Faculdade de Ci?ncias e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal; 5 Department of Applied Bioorganic Chemistry, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, Japan.

* These authors contributed equally to this work.
** Corresponding authors? mailing addresses:
M.M. Institute of Virology, Philipps University, Hans-Meerwein-Str.2, 35043, Marburg, 27 Germany. Phone: 49 6421 286 5166. Fax: 49 6421 286 8962. E-mail: Mikhail.Matrosovich@staff.uni-marburg.de, T.F The Glycosciences Laboratory, Department of Medicine, Imperial College London, Northwick Park and St. Mark?s Campus, Harrow, Middlesex HA1 3UJ, UK. Phone: 44 208 869 3460. Fax: 44 208 8693455. E-mail: t.feizi@imperial.ac.uk.


Abstract

Mutations in the receptor-binding site of the haemagglutinin of pandemic influenza A(H1N1) 2009 viruses have been detected sporadically. An Asp222Gly (D222G) substitution has been associated with severe or fatal disease. Here we show that 222G variants infected a higher proportion of ciliated cells in cultures of human airway epithelium than viruses with 222D or 222E which targeted mainly non-ciliated cells. Carbohydrate microarray analyses showed that 222G variants bind a broader range of α2-3-linked sialyl receptor sequences of a type expressed on ciliated bronchial epithelial cells and on epithelia within the lung. These features of 222G mutants may contribute to exacerbation of disease.

-
-----
 
Back
Top